Related Experiment Video
Updated: Oct 29, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Current Status of Pediatric Formulations for Chronic and Acute Children' Diseases: Applications and Future
Panoraia Siafaka1, Esra Ipekci2, Emre Şefik Caglar2
1Aristotle University of Thessaloniki, Department of Chemistry, Thessaloniki, Greece.
Insights
Developing pediatric medications is challenging due to children's unique physiology and formulation needs. This review summarizes child-friendly drug delivery systems to improve pediatric patient care and safety.
Area of Science:
- Pediatric Pharmacology
- Drug Delivery Systems
- Pharmaceutical Sciences
Background:
- Children face unique health challenges, including rare illnesses.
- Pediatric drug development is complex due to difficulties with standard dosage forms (e.g., tablets) and unlicensed medications.
- Pediatric dosing differs significantly from adults, influenced by age-related variations in drug absorption, distribution, metabolism, and elimination (ADME).
Purpose of the Study:
- To review current drug formulations for pediatric patients.
- To summarize approaches for developing child-friendly drug delivery systems.
- To aid professionals in designing more efficient and safer pediatric medications.
Main Methods:
- Literature review of existing pediatric formulations.
- Summary of therapeutic approaches for pediatric drug delivery.
- Analysis of challenges in pediatric medication administration.
Main Results:
- Various formulations like liquid dosage forms and flexible capsules are used for pediatric patients.
- Children's sensitivity to taste and smell impacts medication adherence.
- Infants are at higher risk for adverse drug events from adult medications.
Conclusions:
- Effective pediatric formulations require consideration of age-specific ADME and patient acceptance.
- Development of child-friendly drug delivery systems is crucial for improving therapeutic outcomes and safety in children.
- This review provides insights for professionals aiming to create better pediatric drug formulations.
Abstract:
Infants and other children can be affected by various acute, chronic and many of them rare illnesses. Developing drugs for children is very challenging since they cannot intake tablets or hard oral solid dosage forms. Besides, most of the prescribed pediatric medications are unlicensed. The biggest issue that clinicians have to solve is that dosing in children is not based on weight or surface area of the body, as it happened in adults but is related to age variations in drug absorption, distribution, metabolism, and elimination. Thus, for pediatric patients, various therapeutic approaches have been proposed so as to develop suitable formulations such as liquid dosage forms, flexible capsules, milk-based products, etc. In addition, the administration of current pharmaceutical products to children might lead to some serious side effects which can also happen in adults but with a lower risk. Especially, infants are at high risk of getting poisoned by taking drugs used for adults. Moreover, children are very sensitive to the taste and smell of some pharmaceutical vehicles and can resist to intake them and this situation leads parents to search for tasteless and odorless medications. In this study, the current formulations for various diseases intended to be used in pediatric patients as well as various chronic and acute diseases of childhood are summarized. Authors believe that this review can help professionals who want to work with pediatric formulations to design more efficient and child-friendly drug delivery systems.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Factors Affecting Drug Response: Overview

